![IJMS | Free Full-Text | Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review IJMS | Free Full-Text | Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review](https://www.mdpi.com/ijms/ijms-22-04955/article_deploy/html/images/ijms-22-04955-g002.png)
IJMS | Free Full-Text | Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review
![Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML) | Journal of Translational Medicine | Full Text Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML) | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-018-1463-1/MediaObjects/12967_2018_1463_Fig1_HTML.gif)
Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML) | Journal of Translational Medicine | Full Text
![Phase I and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies | Leukemia Phase I and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2012.1/MediaObjects/41375_2012_Article_BFleu20121_Fig1_HTML.jpg)
Phase I and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies | Leukemia
![Cytarabine Cytosine Arabinoside Arac Chemotherapy Drug: Stock-Vektorgrafik (Lizenzfrei) 791676376 | Shutterstock Cytarabine Cytosine Arabinoside Arac Chemotherapy Drug: Stock-Vektorgrafik (Lizenzfrei) 791676376 | Shutterstock](https://www.shutterstock.com/image-vector/cytarabine-cytosine-arabinoside-arac-chemotherapy-260nw-791676376.jpg)
Cytarabine Cytosine Arabinoside Arac Chemotherapy Drug: Stock-Vektorgrafik (Lizenzfrei) 791676376 | Shutterstock
![Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-52703-7/MediaObjects/41598_2019_52703_Fig1_HTML.png)
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports
![Cytarabin (cytosinarabinosid, Ara-c) Chemotherapie Medikament Molekül. Verwendet In Der Behandlung Von Akuter Myeloischer Leukämie (aml), Akuter Lymphatischer Leukämie (all) Und Lymphom. Konventionelles Skelettformel Und Stilisierte Darstellungen ... Cytarabin (cytosinarabinosid, Ara-c) Chemotherapie Medikament Molekül. Verwendet In Der Behandlung Von Akuter Myeloischer Leukämie (aml), Akuter Lymphatischer Leukämie (all) Und Lymphom. Konventionelles Skelettformel Und Stilisierte Darstellungen ...](https://previews.123rf.com/images/molekuul/molekuul1412/molekuul141200173/34447403-cytarabin-cytosinarabinosid-ara-c-chemotherapie-medikament-molek%C3%BCl-verwendet-in-der-behandlung.jpg)
Cytarabin (cytosinarabinosid, Ara-c) Chemotherapie Medikament Molekül. Verwendet In Der Behandlung Von Akuter Myeloischer Leukämie (aml), Akuter Lymphatischer Leukämie (all) Und Lymphom. Konventionelles Skelettformel Und Stilisierte Darstellungen ...
![Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (AL Stock Vector Image & Art - Alamy Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (AL Stock Vector Image & Art - Alamy](https://c8.alamy.com/comp/KXYGR0/cytarabine-cytosine-arabinoside-ara-c-chemotherapy-drug-molecule-used-KXYGR0.jpg)
Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (AL Stock Vector Image & Art - Alamy
![The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells - ScienceDirect The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332220310052-ga1.jpg)
The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells - ScienceDirect
![RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia | Pharmacogenomics RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia | Pharmacogenomics](https://www.futuremedicine.com/cms/10.2217/pgs.15.44/asset/images/medium/figure1.gif)
RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia | Pharmacogenomics
![Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-52703-7/MediaObjects/41598_2019_52703_Fig5_HTML.png)
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports
![High-Dose Ara-C with R-CHOP and Autologous Stem Cell Transplant (ASCT) in Mantle-Cell Lymphoma | Research To Practice High-Dose Ara-C with R-CHOP and Autologous Stem Cell Transplant (ASCT) in Mantle-Cell Lymphoma | Research To Practice](http://www.researchtopractice.com/sites/default/files/imagecache/slideshow_image/5mjc/slides/2011/Browse-tumor-types/heme/5mjc_ASH/19/Slide3.jpg)
High-Dose Ara-C with R-CHOP and Autologous Stem Cell Transplant (ASCT) in Mantle-Cell Lymphoma | Research To Practice
![Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells](https://www.mdpi.com/molecules/molecules-22-00499/article_deploy/html/images/molecules-22-00499-g001.png)
Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells
![Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/89c1ed6c-1071-4e12-bc01-c5c9e4936c79/emmm201910419-fig-0001ev-m.jpg)